Author:
Ruppel A.,Rother U.,Diesfeld H. J.,Rauterberg E. W.,Weinke Th.,Alexander M.,Kluge F.,Consbruch U.,Scheer W.,Schulz E.,Dennin R. H.,Sack K.,Dalhoff K.,Dahlhoff K.,Hoyer J.,Wellmann W.,Fink P. C.,Kubale R.,Benner F.,Thilo-Körner D. G. S.,Käufer B.,Lutz F.,Heinrich D.,Lasch H. G.,Seelig R.,Seelig H. P.,Liehr H.,Pott G.
Reference51 articles.
1. Ruppel A, Rother U, Diesfeld HJ (1982) Schistosoma mansoni: development of primary infections in mice genetically deficient or intact in the fifth component of complement. Parasitology 85: 315–323
2. Ruppel A, Rother U, Vongerichten H, Diesfeld HJ (1983) Schistosoma mansoni: complement activation in human and rodent sera by living parasites of various developmental stages. Parasitology 87: 75–86
3. Ruppel A, Rother U, Diesfeld HJ (1984) Schistosoma mansoni: loss of the ability of schistosomula to bind mouse complement following intravenous injection into mice. Tropenmed Parasit 35: 23–28
4. Santoro F, Lachmann PJ, Capron A, Capron M (1979) Activation of complement by Schistosoma mansoni schistosomula: killing of parasites by the alternative pathway and requirement of IgG for classical pathway activation. J Immunol 123: 1551–1557
5. Berning H (1981) Die Chagas-Krankheit und ihre Bedeutung für Mittel-und Südamerika. Munch Med Wochenschr 123: 23–26